Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday.
The Israeli drugmaker stock added 34.5% in the preceding six sessions. The stock has more than doubled so far this year, climbing nearly 115%, dwarfing
